AzTrials
AzTrials

Vesicovaginal FistulaNCT03236922

Autologous Slings With Vesico-Vaginal Fistula Repair

A study testing Pubococcygeus sling and Rectus fascia sling in people with Vesicovaginal Fistula, run by Baylor College of Medicine at 1 site in Malawi.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

It is clear from multiple accounts in the literature that patients with a vesico-vaginal fistula (VVF) involving the bladder neck and/or proximal urethra have a high likelihood of residual incontinence. Performing subsequent surgeries after the initial VVF repair risks additional complications. Read more about this study

Who is it for?
Ages 18 to 90 years, women onlyHealthy volunteers can take part
Conditions the study is for
Vesicovaginal Fistula
What is being tested?
Pubococcygeus sling and Rectus fascia sling
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
1 siteMalawi
Study dates
Jun 2016to Aug 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Women with vesico-vaginal fistulas classified as Goh 3 or 4 at the time of surgery
  • Patients who have consented for an autologous sling
  • Patients who have not previously undergone repair attempt

Who cannot join

  • Patients who require an abdominal approach to the VVF repair
  • Patients found at surgery not to have a Goh 3 or 4 class VVF
  • Patients requiring a complete urethral reconstruction
  • Patients who have undergone previous attempt at repair
  • Patients who require an alternative tissue grafting other than the rectus fascia or pubbococcygeus decided by the surgeon at the time of surgery

Trial locations and contacts

1 site in 1 country.

Malawi1 site
  • Fistula Care Center

    Lilongwe

Other trials in Malawi

About this study

Official title: Pubococcygeus Versus Rectus Sheath Sling for Goh Class 3 and 4 Vesico-vaginal Fistulas: a Randomized Controlled Trial

It is clear from multiple accounts in the literature that patients with a vesico-vaginal fistula (VVF) involving the bladder neck and/or proximal urethra have a high likelihood of residual incontinence. Performing subsequent surgeries after the initial VVF repair risks additional complications. Therefore, placement of an autologous sling at the time of initial VVF repair would not only assist in covering the fistula, but would also imitate the physiologic support that would theoretically improve urethral function. A rectus fascia sling would most naturally provide this support and warrants testing against the success of the PC sling.

Using the Goh scoring criteria, Goh class 3 and 4 VVF's are the type most involving the urethra. Therefore, this group of patients is the target population for this study. As there is currently no standard of care for repairing large urethral defects, this procedural technique combined with otherwise standardized fistula repair would not introduce any foreseeable harm to patients.

Being tested
Pubococcygeus sling, Rectus fascia sling
Keywords
obstetric fistula, anti-incontinence techniques
Medical subject headings
Vesicovaginal Fistula

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pubococcygeus slingProcedure or surgery

    Also called pubococcygeal sling, pubococcygeus graft

    The pubococcygeus muscles is dissected from the vaginal side walls and approximated at the midline just below the urethra.

  • Rectus fascia slingProcedure or surgery

    Also called rectus fascia graft

    Rectus fascia is dissected out cephalad to the pubic symphysis and tunneled beneath the urethra.

Study groups in NCT03236922
Study groupRoleWhat they receive
Pubococcygeus SlingActive comparatorThis is one anti-incontinence technique commonly used at the time of fistula surgery.
Receives: Procedure: Pubococcygeus sling
Rectus Fascia SlingActive comparatorThis is another anti-incontinence technique used at the time of fistula surgery, however, less commonly than the pubococcygeus.
Receives: Procedure: Rectus fascia sling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Long-term Continence Status

    Residual stress incontinence is commonly experienced by this patient population, therefore a dye test to ensure the fistula is still closed and a cough test to determine any incontinence will be performed.

    Measured: Six months after surgery

Secondary outcomes (1)
  1. Vesico-vaginal fistula repaired

    To ensure the VVF is still closed and was not compromised due to the sling

    Measured: One month after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2017
  2. Study startJun 2016
  3. Primary completionAug 2018 (estimated)
  4. Study completionAug 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03236922
Sponsor's protocol ID
H-38672
Status last verified
Jul 2017
First submitted
21 Aug 2016
Last updated
2 Aug 2017
Results posted
No
Data monitoring committee
Yes
Individual data sharing
Yes: No.

Publications

  • Ascher-Walsh CJ, Capes TL, Lo Y, Idrissa A, Wilkinson J, Echols K, Crawford B, Genadry R. Sling procedures after repair of obstetric vesicovaginal fistula in Niamey, Niger. Int Urogynecol J. 2010 Nov;21(11):1385-90. doi: 10.1007/s00192-010-1202-5. Epub 2010 Jun 17.

    PubMed 20556597
  • Browning A. Risk factors for developing residual urinary incontinence after obstetric fistula repair. BJOG. 2006 Apr;113(4):482-5. doi: 10.1111/j.1471-0528.2006.00875.x. Epub 2006 Feb 20.

    PubMed 16489933
  • Browning A. Prevention of residual urinary incontinence following successful repair of obstetric vesico-vaginal fistula using a fibro-muscular sling. BJOG. 2004 Apr;111(4):357-61. doi: 10.1111/j.1471-0528.2004.00080.x.

    PubMed 15008773
  • Carey MP, Goh JT, Fynes MM, Murray CJ. Stress urinary incontinence after delayed primary closure of genitourinary fistula: a technique for surgical management. Am J Obstet Gynecol. 2002 May;186(5):948-53. doi: 10.1067/mob.2002.122247.

    PubMed 12015520
  • Pope R, Browning A, Chipungu E, George JOM, Tamimu M, Wilkinson J. Prophylactic Autologous Slings at the Time of Obstetric Fistula Repair: A Randomized Clinical Trial. Female Pelvic Med Reconstr Surg. 2021 Feb 1;27(2):78-84. doi: 10.1097/SPV.0000000000000745.

    PubMed 31145227

Questions about this trial

What is this clinical trial studying?

A study testing Pubococcygeus sling and Rectus fascia sling in people with Vesicovaginal Fistula, run by Baylor College of Medicine at 1 site in Malawi.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Malawi. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Long-term Continence Status (time frame: Six months after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03236922, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in